FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, chemical-pharmaceutical and cosmetic industry, namely to method of producing liposomal form ubiquinol (reduced Coenzyme Q10), involving preparation of solution, containing mixture of phospholipid and sterol in weight ratio of 1:0.1-2 respectively, ubiquinol with weight ratio of ubiquinol to mixture of phospholipid and sterol equal to 1:1-4, respectively, and co-solvent in form of nonionic surfactant in ethanol, dispersion of obtained solution, containing lipid fraction, in aqueous medium containing cryoprotectant to obtain suspension of lipid vesicles with ubiqinol in them, homogenization of suspension of lipid vesicles and separation of liposomes with size no more than 220 nm with ubiquinol included therein, as well as to liposomal pharmaceutical and cosmetic compositions including liposomal form of ubiquinol obtained using said method.
EFFECT: group of inventions provides higher bioavailability of coenzyme Q10, higher capture factor and stability of retention of coenzyme Q10 in liposomes.
24 cl, 12 ex, 1 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
BIS-NAPHTHAZARIN BASED AGENT AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2669374C2 |
UBIQUINOL COMPOSITION FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2635993C1 |
AGENT WITH ISONIAZID-CONTAINING LIPOSOMES | 2016 |
|
RU2622755C1 |
PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL APPLICATION FOR INCREASE OF DRUG ACTIVITY AND DECREASE OF SIDE EFFECTS | 2010 |
|
RU2469706C2 |
LIPOSOMAL COMPOSITIONS CONTAINING SLIGHTLY ACIDIC DRUGS, AND THEIR USE | 2018 |
|
RU2778886C2 |
METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
LIPOSOMAL COMPOSITION AND METHOD OF ITS PREPARATION | 2012 |
|
RU2514000C1 |
LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
LIPOSOMAL COMPOSITION AND METHOD FOR PRODUCTION THEREOF | 2012 |
|
RU2516893C1 |
Authors
Dates
2016-12-27—Published
2015-11-27—Filed